Replies to post #85640 on Cytodyn Inc (CYDY)

[hitekmastr]

Totally agree. Even a worst case scenario is spectacular. Best case is off the chart. Uplisting will give a boost. The 22 "basket of cancers" trial will help prioritize which cancers to target next. GOOD LUCK.

[RationalBeing]

I am with you, there is nothing to suggest failure other than concern over the short term financial health. With the stock price holding higher (discounting today), and the pending authorization of more shares to be used as needed (and per NP likely at far less shares sold than authorized), I consider some minimal dilution to be well worth buying time to bring the baby out out the incubator to full health.

[EponymousKook]

“If it worked with HIV it should work on any flue, Covid-19 included.”

Oy vey.

[Chuckles759]

Black-Ops,

Regarding your comparison of HIV, Influenza A/B, and COVID-19 there are some significant differences.

Influenza A/B could be loosely compared to COVID-19; however, HIV is a completely different and vicious beast.

Here's a good article explaining the differences:

https://www.news-medical.net/health/What-is-the-Difference-Between-COVID-19-and-the-Flu.aspx

---edit---
whoops...correct link to differences between flu and HIV
http://www.differencebetween.net/science/health/difference-between-hivaids-and-flu/
---edit---

Everything else in your post is encouraging conformation of my personal choices for investment. I've started retirement investment accounts for two of my kids over 18yo and seeded it each a few thousand shares of CYDY to get them started. The key is....they can't touch it until 59 1/2...or if they change the laws again to let people withdraw with little or no penalty...or if the government annexes control over individual retirement accounts to "help" the SSA remain solvent....but I digress and that's another discussion.

[Amatuer17]

Doing the calculation using same assumptions 1000 times will give same results. But what if the assumptions are wrong?

Your no of dose selling in first year itself is wrong - that many cases do not even exist. NP has put a price point - what if that itself is too high?
Market cap is around $3 B - looking at good results a BP buys it for $12 B (that is 4 times current market cap
All this assumes that results are great - what if the trial results are just good or not as good?

Change these parameters and your calculations falter. Good results and buyout is a clear possibility and at that point people will good money - like 4 bagger from here but not boatload you are calculating